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Aspirin and clopidogrel are the two effective anti platelet
drugs which are used in loading doses in other vascular
events like cardiac to prevent further deterioration. The
value of this approach for the brain is not known. 
What is the study design?
This pilot study was conducted to assess the safety and
efficacy of the double anti platelet agents in loading
doses in patient with acute ischaemic stroke presenting
within 36 hours of onset of symptoms.
Who were the patients?
Forty patients were enrolled from a single stroke center in
six months. All the patients were diagnosed to have stroke
or TIA by examination from a stroke specialist fitting their
inclusion criteria. Primary safety aim was symptomatic
haemorrhage with a secondary end point of neurological
detoriation. 
What were the results?
The dose appeared to be safe as no acute intracranial
haemorrhages were detected with no mortality. Only a
single symptomatic intracranial haemorrhage 2.5% was
detected 43days post treatment. None of the patients
experienced neurological detoriation within 24hrs and
97% had no detoriation by 7 days of treatment. Treatment
was compared with matched control patients.
The author concluded that high loading doses of two
antiplatelet agents were effective in the treatment of
patient with acute ischaemic stroke within 36hrs of onset.
Why is this study important? 
This study provides successful ground for the safety and
efficacy of these drugs for future studies in the treatment
of acute ischaemic stroke not fulfilling the criteria of acute
revascularization.In Pakistan cost of r tPA limits
revascularization therapy in many of eligible patients with
stroke. This trial has shown promising result for loading
doses of aspirin and Clopidogrel safety, and we should
await efficacy results before we start loading 2 agents for
every patient. However, this is a promising alternative for
a resource strapped region. 
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